BLTE
Price
$112.41
Change
+$1.59 (+1.43%)
Updated
Nov 13 closing price
Capitalization
3.94B
133 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$20.56
Change
-$0.76 (-3.56%)
Updated
Nov 13 closing price
Capitalization
14.3B
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLTE vs ROIV

Header iconBLTE vs ROIV Comparison
Open Charts BLTE vs ROIVBanner chart's image
Belite Bio
Price$112.41
Change+$1.59 (+1.43%)
Volume$45.24K
Capitalization3.94B
Roivant Sciences
Price$20.56
Change-$0.76 (-3.56%)
Volume$8.08M
Capitalization14.3B
BLTE vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
BLTE vs. ROIV commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Hold and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BLTE: $112.41 vs. ROIV: $20.56)
Brand notoriety: BLTE and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 58% vs. ROIV: 91%
Market capitalization -- BLTE: $3.94B vs. ROIV: $14.3B
BLTE [@Biotechnology] is valued at $3.94B. ROIV’s [@Biotechnology] market capitalization is $14.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 2 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • BLTE’s TA Score: 2 bullish, 3 bearish.
  • ROIV’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а +0.61% price change this week, while ROIV (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BLTE is expected to report earnings on Mar 27, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($14.3B) has a higher market cap than BLTE($3.94B). ROIV (80.220) and BLTE (78.146) have similar YTD gains . BLTE has higher annual earnings (EBITDA): -50.43M vs. ROIV (-1.18B). ROIV has higher revenues than BLTE: ROIV (23.2M) vs BLTE (0).
BLTEROIVBLTE / ROIV
Capitalization3.94B14.3B28%
EBITDA-50.43M-1.18B4%
Gain YTD78.14680.22097%
P/E RatioN/A1.97-
Revenue023.2M-
Total CashN/A4.5B-
Total DebtN/A99.7M-
TECHNICAL ANALYSIS
Technical Analysis
BLTEROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 3 days ago
61%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXU197.0418.53
+10.38%
MicroSectors™ Gold Miners 3X Lvrgd ETN
JETU24.611.09
+4.64%
MAX Airlines 3X Leveraged ETN
CIL53.180.43
+0.81%
VictoryShares International Vol Wtd ETF
GAUG38.87-0.04
-0.11%
FT Vest U.S. Eq Mod Buffr ETF - Aug
QHY46.46-0.09
-0.19%
WisdomTree US Hi Yld Corp Bd

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+1.44%
RAIN - BLTE
48%
Loosely correlated
+6.10%
ACOG - BLTE
26%
Poorly correlated
+0.16%
ROIV - BLTE
23%
Poorly correlated
-3.56%
AGIO - BLTE
22%
Poorly correlated
-2.50%
APLS - BLTE
22%
Poorly correlated
-1.05%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+2.01%
IMVT - ROIV
60%
Loosely correlated
+2.40%
RVMD - ROIV
52%
Loosely correlated
+2.73%
ACLX - ROIV
50%
Loosely correlated
-0.09%
XENE - ROIV
50%
Loosely correlated
-0.60%
IRON - ROIV
49%
Loosely correlated
-0.06%
More